Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Bind Biosciences appoints Dr Ed Schnipper

July 6, 2010 Manufacturing and Production, Research and Development Bind Bioscience, appointment, manufacturing and production, research and development

US biopharmaceutical company Bind Biosciences has appointed Dr Ed Schnipper as chief medical officer. Dr Schnipper joins the company with …
Appointment
Roche BioOncology iPhone app

Digital Pharma: Big pharma’s iPhone apps (part two)

July 5, 2010 Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, ipad, iphone

Part one of Big Pharma’s iPhone Apps covered apps produced by Pfizer, Merck & Co, GlaxoSmithKline, Sanofi-Aventis and Novartis and …
Feature

AstraZeneca collaborates on compound library

July 5, 2010 Research and Development AstraZeneca, MRC

AstraZeneca and the UK’s Medical Research Council are to share access to their compounds to improve their efforts to find …
News

Lilly set to acquire Alnara Pharmaceuticals

July 5, 2010 Research and Development, Sales and Marketing Alnara, Liprotamase, cystic fibrosis, enzyme replacement therapy, lilly

Lilly is to acquire US-based biotech firm Alnara and will take hold of its lead product Liprotamase for pancreatic enzyme …
News

Ovarian cancer trial boost for Avastin

July 5, 2010 Research and Development Roche, avastin, ovarian cancer

Roche’s blockbuster oncology drug Avastin has met its primary endpoint of improving progression-free survival in women with ovarian cancer in …
News
GSK workers protest

Aptuit deal saves GSK’s R&D unit in Verona

July 5, 2010 Manufacturing and Production, Research and Development Aptuit, GlaxoSmithKline, Italy

GlaxoSmithKline has sold off its medicines research facility in Verona, Italy, to contract research and manufacturing service group Aptuit in …
News
Pfizer Oncology iPhone app

Digital Pharma: Big pharma’s iPhone apps (part one)

July 2, 2010 Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, digital pharma, ipad, iphone

Most sectors of business have been eagerly eyeing, and responding to, the potential of Apple’s iPhone, and this year’s iPad …
Feature

No sign of revival in R&D productivity

June 30, 2010 Research and Development drug development, industry, research

New data on the performance of the pharmaceutical industry shows efforts to raise productivity have not yet made an impact. …
News
Indian flag

US and India advance healthcare co-operation

June 30, 2010 Research and Development, Sales and Marketing India, h1n1, medical schools

The US and India are looking to establish closer ties between their top medical schools. The initiative was one of …
News

Sanofi acquires US biotech TargeGen

June 30, 2010 Research and Development Sanofi, TargeGen, haematology

Sanofi-Aventis is to buy TargeGen, a US biopharmaceutical company which develops small molecule kinase inhibitors. The drugs are used to …
News

Contract research news in brief

June 30, 2010 Research and Development CRO

Yet more geographic expansion from leading CROs, with Kendle opening an office in India and PRA International announcing a Hungarian …
News

Real World Development: Increasing value for patients

June 30, 2010 Research and Development Kinapse, drug development

The traditional drug development paradigm is protracted and costly, with many products failing to deliver commercial or clinical success.We propose …
Feature

Boehringer cheered by diabetes data

June 28, 2010 Research and Development Boehringer, DPP-4, diabetes, linagliptin

Boehringer Ingelheim has been cheered by phase III data showing its new oral once-daily type II diabetes tablet linagliptin significantly …
News

New anti-clotting drugs: stopping the silent killers

June 28, 2010 Research and Development, Sales and Marketing Pradaxa, VTE, Xarelto, atrial fibrilation, thrombosis

Blood clots are a major killer, but the threat they pose is poorly understood by the general public compared to …
Feature

Sanofi licences novel oral anti-diabetic treatment

June 25, 2010 Research and Development, Sales and Marketing Metabolex, Sanofi-Aventis, diabetes

Sanofi-Aventis has signed an exclusive worldwide licensing agreement with US-based diabetes specialist Metabolex for a novel oral anti-diabetic treatment. MBX-2982 …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026